70579-62-3 Usage
Description
(R)-2-tridecyl-2,5-dihydro-4-methyl-5-oxo-3-furoic acid is a complex organic compound belonging to the furoic acid family, characterized by a unique molecular structure that includes a tridecyl chain, a furan ring, and a carboxylic acid group. The "(R)" prefix denotes the specific stereochemistry of the molecule, which is crucial for its potential applications and interactions. This fatty acid derivative may hold promise in various fields such as organic synthesis, pharmaceuticals, and materials science, although further research is necessary to explore its full potential.
Uses
Used in Organic Synthesis:
(R)-2-tridecyl-2,5-dihydro-4-methyl-5-oxo-3-furoic acid is used as a building block in organic synthesis for creating a variety of complex molecules due to its unique structural features, including a tridecyl chain and a furan ring.
Used in Pharmaceutical Applications:
In the pharmaceutical industry, (R)-2-tridecyl-2,5-dihydro-4-methyl-5-oxo-3-furoic acid is used as a potential therapeutic agent, leveraging its unique molecular structure to target specific biological pathways or receptors that may be implicated in various diseases.
Used in Materials Science:
(R)-2-tridecyl-2,5-dihydro-4-methyl-5-oxo-3-furoic acid is used as a component in the development of novel materials, potentially contributing to the creation of advanced materials with specific properties, such as improved stability or reactivity, based on its chemical composition and structure.
Check Digit Verification of cas no
The CAS Registry Mumber 70579-62-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,0,5,7 and 9 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 70579-62:
(7*7)+(6*0)+(5*5)+(4*7)+(3*9)+(2*6)+(1*2)=143
143 % 10 = 3
So 70579-62-3 is a valid CAS Registry Number.
InChI:InChI=1/C19H32O4/c1-3-4-5-6-7-8-9-10-11-12-13-14-16-17(18(20)21)15(2)19(22)23-16/h16H,3-14H2,1-2H3,(H,20,21)/t16-/m1/s1
70579-62-3Relevant articles and documents
Design, synthesis and biological evaluation of potential antibacterial butyrolactones
Sweidan, Alaa,Chollet-Krugler, Marylene,van de Weghe, Pierre,Chokr, Ali,Tomasi, Sophie,Bonnaure-Mallet, Martine,Bousarghin, Latifa
, p. 5823 - 5833 (2016/10/30)
Novel butyrolactone analogues were designed and synthesized based on the known lichen antibacterial compounds, lichesterinic acids (B-10 and B-11), by substituting different functional groups on the butyrolactone ring trying to enhance its activity. All synthesized butyrolactone analogues were evaluated for their in vitro antibacterial activity against Streptococcus gordonii. Among the derivatives, B-12 and B-13 had the lowest MIC of 9.38 μg/mL where they have shown to be stronger bactericidals, by 2–3 times, than the reference antibiotic, doxycycline. These two compounds were then checked for their cytotoxicity against human gingival epithelial cell lines, Ca9–22, and macrophages, THP-1, by MTT and LDH assays which confirmed their safety against the tested cell lines. A preliminary study of the structure–activity relationships unveiled that the functional groups at the C4position had an important influence on the antibacterial activity. An optimum length of the alkyl chain at the C5position registered the best antibacterial inhibitory activity however as its length increased the bactericidal effect increased as well. This efficiency was attained by a carboxyl group substitution at the C4position indicating the important dual role contributed by these two substituents which might be involved in their mechanism of action.
